BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Dong Y, Zhao J, Zhang L, Kong L, Lu JJ. Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines. Ann Transl Med 2019;7:542. [PMID: 31807524 DOI: 10.21037/atm.2019.09.128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Mirjolet C, Nicol A, Limagne E, Mura C, Richard C, Morgand V, Rousseau M, Boidot R, Ghiringhelli F, Noel G, Burckel H. Impact of proton therapy on antitumor immune response. Sci Rep 2021;11:13444. [PMID: 34188135 DOI: 10.1038/s41598-021-92942-1] [Reference Citation Analysis]
2 Helm A, Fournier C, Durante M. Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications. Expert Rev Mol Med 2022;24:e8. [PMID: 35101155 DOI: 10.1017/erm.2022.2] [Reference Citation Analysis]
3 Vaes RDW, Reynders K, Sprooten J, Nevola KT, Rouschop KMA, Vooijs M, Garg AD, Lambrecht M, Hendriks LEL, Rucevic M, De Ruysscher D. Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study. Cancers (Basel) 2021;13:6259. [PMID: 34944879 DOI: 10.3390/cancers13246259] [Reference Citation Analysis]
4 Tubin S, Fossati P, Carlino A, Martino G, Gora J, Stock M, Hug E. Novel Carbon Ion and Proton Partial Irradiation of Recurrent Unresectable Bulky Tumors (Particle-PATHY): Early Indication of Effectiveness and Safety. Cancers 2022;14:2232. [DOI: 10.3390/cancers14092232] [Reference Citation Analysis]
5 Zheng J, Sun J, Chen J, Zhu S, Chen S, Liu Y, Hao L, Wang Z, Chang S. Oxygen and oxaliplatin-loaded nanoparticles combined with photo-sonodynamic inducing enhanced immunogenic cell death in syngeneic mouse models of ovarian cancer. Journal of Controlled Release 2021;332:448-59. [DOI: 10.1016/j.jconrel.2021.02.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang J, Dai Z, Miao Y, Zhao T, Gan J, Zhao C, Ran J, Guan Q. Carbon ion (12C6+) irradiation induces the expression of Klrk1 in lung cancer and optimizes the tumor microenvironment based on the NKG2D/NKG2D-Ls pathway. Cancer Lett 2021;521:178-95. [PMID: 34492331 DOI: 10.1016/j.canlet.2021.09.003] [Reference Citation Analysis]
7 Görgen A, Guttormsen M, Larsen AC, Siem S, Adli E, Edin NFJ, Gjersdal H, Henriksen G, Malinen E, Modamio V, Schoultz B, Sobas PA, Theodossiou TA, Wikne JC. The Oslo Cyclotron Laboratory. Eur Phys J Plus 2021;136. [DOI: 10.1140/epjp/s13360-021-01150-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vaes RDW, Hendriks LEL, Vooijs M, De Ruysscher D. Biomarkers of Radiotherapy-Induced Immunogenic Cell Death. Cells 2021;10:930. [PMID: 33920544 DOI: 10.3390/cells10040930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zhang M, Fang Z, Cui M, Liu K. Multifunctional Metal Complex-based Gene Delivery for tumor immune checkpoint blockade combination therapy. J Drug Target 2022;:1-34. [PMID: 35311603 DOI: 10.1080/1061186X.2022.2056186] [Reference Citation Analysis]
10 Zhu M, Yang M, Zhang J, Yin Y, Fan X, Zhang Y, Qin S, Zhang H, Yu F. Immunogenic Cell Death Induction by Ionizing Radiation. Front Immunol 2021;12:705361. [PMID: 34489957 DOI: 10.3389/fimmu.2021.705361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Y, Li X, Yang J, Wang S, Tang M, Xia J, Gao Y. Flourish of Proton and Carbon Ion Radiotherapy in China. Front Oncol 2022;12:819905. [DOI: 10.3389/fonc.2022.819905] [Reference Citation Analysis]
12 Hernández ÁP, Juanes-Velasco P, Landeira-Viñuela A, Bareke H, Montalvillo E, Góngora R, Fuentes M. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers (Basel) 2021;13:2821. [PMID: 34198850 DOI: 10.3390/cancers13112821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Takahashi J, Nagasawa S. Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review. Int J Mol Sci 2020;21:E9324. [PMID: 33297519 DOI: 10.3390/ijms21239324] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 Ran J, Wang J, Dai Z, Miao Y, Gan J, Zhao C, Guan Q. Irradiation-Induced Changes in the Immunogenicity of Lung Cancer Cell Lines: Based on Comparison of X-rays and Carbon Ions. Front Public Health 2021;9:666282. [PMID: 33968889 DOI: 10.3389/fpubh.2021.666282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sato H, Okonogi N, Nakano T. Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment. Int J Clin Oncol 2020;25:801-9. [PMID: 32246277 DOI: 10.1007/s10147-020-01666-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
16 Zhou H, Sun F, Ou M, Zhang Y, Lin M, Song L, Yu Y, Liao H, Fan W, Xing H, Li M, Zhao K, Wu X, Sun Y, Liang C, Cai Y, Cui L. Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury. Mol Ther 2021:S1525-0016(21)00325-7. [PMID: 34174438 DOI: 10.1016/j.ymthe.2021.06.019] [Reference Citation Analysis]
17 Marcus D, Lieverse RIY, Klein C, Abdollahi A, Lambin P, Dubois LJ, Yaromina A. Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy. Cancers (Basel) 2021;13:1468. [PMID: 33806808 DOI: 10.3390/cancers13061468] [Reference Citation Analysis]
18 Huang Y, Huang Q, Zhao J, Dong Y, Zhang L, Fang X, Sun P, Kong L, Lu JJ. The Impacts of Different Types of Radiation on the CRT and PDL1 Expression in Tumor Cells Under Normoxia and Hypoxia. Front Oncol 2020;10:1610. [PMID: 32974200 DOI: 10.3389/fonc.2020.01610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Keisari Y, Kelson I. The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules. Cells 2021;10:228. [PMID: 33503958 DOI: 10.3390/cells10020228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]